Archive ready

株式会社トランスジェニック 事業計画及び成長可能性に関する説明資料

https://transgenic-group.co.jp/ir/library/business_plan/20210813-2.pdf
May 8, 2026 at 02:15 PM JSTThe archive page, viewer, and downloads use this saved version.
May 8, 2026 at 02:15 PM JST·transgenic-group.co.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved PDF

株式会社トランスジェニック 事業計画及び成長可能性に関する説明資料

StartedMay 8, 2026 at 02:15 PM JST
File size3.58 MB
SHA-256a87fd39808e368bcf61d767aceea51c41f0d16eba90ea306ca3b7ecec4e3955d
About this pageAI generated

This document is the business plan and growth potential explanation material of TransGenic Inc., dated August 13, 2021. It includes company overview, business model, market environment, growth strategy, and risk information. TransGenic leverages cutting-edge biotechnology to provide seamless support from basic research to clinical trials in its drug discovery support business, while also engaging in succession-type M&A. The document outlines the company's efforts to stabilize revenue through its drug discovery support services and discusses market conditions and competitive advantages, highlighting future growth strategies.